Trademark: COPE 1693259
Word
COPE
ID
1693259
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
13 May 2015
Registration Date
13 May 2015
Renewal Date
13 May 2025
Owner(s)
Service
Spruson & Ferguson
Goods and Services:
Class 35:
Data collection services in relation to analytical and clinical purposes, in particular the collection and systematic sorting of specific molecular, genomic and/or clinical data relating to genomic changes, namely, cancer genomic changes, of an individual, namely of a company's employee; data collection services for analytical purposes, in particular the collection of mathematical and statistical data, clinical data, genomic data and data of clinical studies relating to the employees' clinical responses to drug treatments and treatment regimes; collection of cancer-associated genetic and treatment information, for the purposes of providing medical treatment and diagnosis for individuals, namely employees
Data collection services in relation to analytical and clinical purposes, in particular the collection and systematic sorting of specific molecular, genomic and/or clinical data relating to genomic changes, namely, cancer genomic changes, of an individual, namely of a company's employee; data collection services for analytical purposes, in particular the collection of mathematical and statistical data, clinical data, genomic data and data of clinical studies relating to the employees' clinical responses to drug treatments and treatment regimes; collection of cancer-associated genetic and treatment information, for the purposes of providing medical treatment and diagnosis for individuals, namely employees
Class 36:
Administration of programs for payment of treatment decision support programs and treatment for cancer as an employee benefit
Administration of programs for payment of treatment decision support programs and treatment for cancer as an employee benefit
Class 42:
Providing scientific information through the collection and analysis of genetic information and disorders; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis and analysis services in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients, in particular genomic data obtained from employees; providing scientific information on employees´ genomic changes that contribute to a unique cancer disease; providing research information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individuals, namely employees; scientific consulting services in the fields of pharmaceuticals and genetics, in particular conducting scientific research in drug safety and dosage assessment and drug compatibility studies in the field of cancer treatment therapy for others; electronic storage of medical data and information for physicians and healthcare professionals
Providing scientific information through the collection and analysis of genetic information and disorders; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis and analysis services in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients, in particular genomic data obtained from employees; providing scientific information on employees´ genomic changes that contribute to a unique cancer disease; providing research information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individuals, namely employees; scientific consulting services in the fields of pharmaceuticals and genetics, in particular conducting scientific research in drug safety and dosage assessment and drug compatibility studies in the field of cancer treatment therapy for others; electronic storage of medical data and information for physicians and healthcare professionals
Class 44:
Providing medical and diagnostic information via on-line databases, including information in relation to prophylactic and therapeutic properties of pharmaceuticals, and genomic information as it relates to medical diagnosis and treatment; pharmaceutical consulting services in pharmaceuticals and genetics in relation to medical treatment options, in particular in the field of clinical diagnostics and therapy, in particular in the field of cancer diagnostics and cancer therapy, namely, medical consulting services in form of treatment decision support services that guide physicians and patients in the use of genetic clinical molecular and efficacy data; medical consulting services in form of providing treatment decision support programs to employers which enable employers and their affiliates to offer disease treatment decision support programs as a service to their employees, family members and/or spouses, namely, in form of an employee benefit to eligible individuals; medical consulting services in form of providing disease treatment decision support services to employees or their treating physicians which enable employers and their affiliates to offer such treatment decision support services as a service to their employees, family members and/or spouses, namely, in form of an employee benefit to eligible individuals; medical consulting services in form of disease treatment decision support services provided by a company or other employer to its employees, namely the provision of state of the art treatment options for diseases, in particular, cancer treatment options; cancer genomic and molecular medical testing, in particular by using next generation sequencing methods that utilizes the analysis of genomic changes by next generation sequencing of DNA samples provided by and/or derived from individuals participating in the employees´ benefit program; information in relation to an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice provided online; consulting services to employers in the field of offering medical treatment support programs to employees as an employee benefit, in particular consulting services which enable the employer to offer treatment decision support programs to eligible individuals, namely, in form of offering eligible individuals free-of-charge access to cancer treatment decision support programs and services; services provided by an employer to its employees whereby the employer will offer or make available disease treatment decision support services, such as with respect to cancer, or other diagnostic services, to its employees and/or the employees' respective physicians or other healthcare providers as an employee benefit; consultation in regard to medical and disease treatment support programs
Providing medical and diagnostic information via on-line databases, including information in relation to prophylactic and therapeutic properties of pharmaceuticals, and genomic information as it relates to medical diagnosis and treatment; pharmaceutical consulting services in pharmaceuticals and genetics in relation to medical treatment options, in particular in the field of clinical diagnostics and therapy, in particular in the field of cancer diagnostics and cancer therapy, namely, medical consulting services in form of treatment decision support services that guide physicians and patients in the use of genetic clinical molecular and efficacy data; medical consulting services in form of providing treatment decision support programs to employers which enable employers and their affiliates to offer disease treatment decision support programs as a service to their employees, family members and/or spouses, namely, in form of an employee benefit to eligible individuals; medical consulting services in form of providing disease treatment decision support services to employees or their treating physicians which enable employers and their affiliates to offer such treatment decision support services as a service to their employees, family members and/or spouses, namely, in form of an employee benefit to eligible individuals; medical consulting services in form of disease treatment decision support services provided by a company or other employer to its employees, namely the provision of state of the art treatment options for diseases, in particular, cancer treatment options; cancer genomic and molecular medical testing, in particular by using next generation sequencing methods that utilizes the analysis of genomic changes by next generation sequencing of DNA samples provided by and/or derived from individuals participating in the employees´ benefit program; information in relation to an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice provided online; consulting services to employers in the field of offering medical treatment support programs to employees as an employee benefit, in particular consulting services which enable the employer to offer treatment decision support programs to eligible individuals, namely, in form of offering eligible individuals free-of-charge access to cancer treatment decision support programs and services; services provided by an employer to its employees whereby the employer will offer or make available disease treatment decision support services, such as with respect to cancer, or other diagnostic services, to its employees and/or the employees' respective physicians or other healthcare providers as an employee benefit; consultation in regard to medical and disease treatment support programs